The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist
Nevi L.;
2018-01-01
Abstract
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonistFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
AISF 2018 Programma poster FXR.pdf
non disponibili
Licenza:
Non specificato
Dimensione
397.81 kB
Formato
Adobe PDF
|
397.81 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
